TARGET

When the heart is the target

Cardiac radioablation puts an ablative dose into the heart itself. The target moves with every beat and every breath. Everything around it is tissue you want to keep.

01 / Why it matters

Every millimetre of margin is healthier heart

Millions live with arrhythmias that drugs and catheters fail to stop. Radiation can reach the substrate from outside the body. Motion is what stands in the way.

~50 MLive with an arrhythmia*
~5.5 MVentricular arrhythmias*

Catheter ablation The therapy today*

CardioKit radioablation What we aim for**

20–80%Acute success, idiopathic to scar-related VT*
~90%Success we expect from a gated session**
2–7 hInvasive procedure, up to 10 staff*
~2 hNon-invasive, beam from outside the body†

GBD 2019 (59.7 M with atrial fibrillation or flutter alone), 2019 HRS/EHRA consensus (20–80 %, idiopathic to scar-related VT), Global Market Insights, Congruence Market Insights (2025). ~5.5 M, 90,000 procedures a year, 2–7 h and staff counts are EBAMed estimates. More on the evidence page.
~90 % and ~2 h are the targets EBAMed designs CardioKit against, not clinical results.

02 / Dual gating

Two rhythms, one gating window

Respiratory gating is routine using surrogates.
Cardio-respiratory gating is not, because nothing in the treatment room sees the heart in real-time.

Primary focus today

INDICATION 01

Ventricular tachycardia

Scar-related VT after failed catheter ablation. The first indication, with the largest published record, and the one CardioKit is being built and trialled for.

Read →

What we aim for next

INDICATION 02

Primary cardiac sarcoma

A malignant tumor of the heart wall. Rarely resectable in full. Moves with the muscle it grows from.

INDICATION 03

Septal reduction in HOCM

Thinning the septum that blocks outflow in hypertrophic cardiomyopathy. No surgery, no catheter.

03 / Ventricular tachycardia

An electrical circuit trapped in scar.

Stereotactic arrhythmia radioablation, STAR. One dose of radiation switches off a rhythm disorder.

Sinus · 60 bpm VT · ~190 bpm
Monomorphic VT
LV SCAR · REENTRY CIRCUIT ABLATED VOLUME
Schematic. Left ventricle, short axis.

Deliver one dose to the scar driving the arrhythmia. The same tissue a catheter would burn, reached from outside the body. Protons stop at a chosen depth and deliver the dose on the target.

In weeks, conduction through the scar is disrupted. In months, fibrosis breaks the circuit for good. One session, outpatient. No anesthesia, no catheter.